相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
K. V. Menon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma
Tomoharu Yoshizumi et al.
HEPATOLOGY RESEARCH (2013)
Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center
An Bin Hu et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
THE CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS AMELIORATES RENAL FUNCTION AND PREVENTS HEPATOCELLULAR CARCINOMA WITHOUT ANY EPISODE OF REJECTION
E. Cholongitas et al.
JOURNAL OF HEPATOLOGY (2013)
EVEROLIMUS IN LIVER TRANSPLANTATION TO PREVENT HEPATOCELLULAR CARCINOMA RECURRENCE IN THE PRESENCE OF EXTENDED MILAN CRITERIA
P. Houssel et al.
JOURNAL OF HEPATOLOGY (2013)
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Takashi Motomura et al.
JOURNAL OF HEPATOLOGY (2013)
Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
Emmanuel Tsochatzis et al.
LIVER INTERNATIONAL (2013)
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation - PROTECT
L. Fischer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
P. De Simone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Optimization of the use of Calcineurin inhibitors in liver transplantation
E. L. D. de Mare-Bredemeijer et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Results of a Phase 4 Trial of Tacrobell® in Liver Transplantation Patients: A Multicenter Study in South Korea
Young-Dong Yu et al.
HEPATO-GASTROENTEROLOGY (2012)
Steroid elimination within 24 hours after orthotopic liver transplantation: effectiveness and tolerability
Lin-Wei Wu et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2012)
Beyond the Milan Criteria What Risks for Patients With Hepatocellular Carcinoma Progression Before Liver Transplantation?
Luciano De Carlis et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Liver Transplantation for Hepatocellular Carcinoma: Long-Term Results Suggest Excellent Outcomes
M. B. Majella Doyle et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
Wenhua Liang et al.
LIVER TRANSPLANTATION (2012)
Factors that affect deceased donor liver transplantation rates in the United States in addition to the model for end-stage liver disease score
Pratima Sharma et al.
LIVER TRANSPLANTATION (2012)
Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma
Ho Jung An et al.
LIVER TRANSPLANTATION (2012)
Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up
Richard S. Mangus et al.
LIVER TRANSPLANTATION (2012)
Routine Induction Therapy in Living Donor Liver Transplantation Prevents Rejection but May Promote Recurrence of Hepatitis C
A. Ghanekar et al.
TRANSPLANTATION PROCEEDINGS (2012)
Hepatocellular Carcinoma Recurrence Among Liver Transplant Recipients Within the Milan Criteria
G. Felga et al.
TRANSPLANTATION PROCEEDINGS (2012)
The Relationship Between Recurrences and Immunosuppression on Living Donor Liver Transplantation for Hepatocellular Carcinoma
S. Miyagi et al.
TRANSPLANTATION PROCEEDINGS (2012)
Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Is an Active Surveillance for Recurrence Needed?
J. F. Castroagudin et al.
TRANSPLANTATION PROCEEDINGS (2012)
Reduced-Dose Tacrolimus with Mycophenolate Mofetil vs. Standard-Dose Tacrolimus in Liver Transplantation: A Randomized Study
K. Boudjema et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria
Kheng-Choon Lim et al.
ANNALS OF SURGERY (2011)
Significance of Tumor Necrosis for Outcome of Patients with Hepatocellular Carcinoma Receiving Locoregional Therapy Prior to Liver Transplantation
Kun-Ming Chan et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin
Evangelos Cholongitas et al.
CLINICAL TRANSPLANTATION (2011)
Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis
Katrin Hoffmann et al.
CLINICAL TRANSPLANTATION (2011)
Long-term experience with liver transplantation for hepatocellular carcinoma
Georgios Tsoulfas et al.
JOURNAL OF GASTROENTEROLOGY (2011)
m-TOR inhibitors: What role in liver transplantation?
Toshiyasu Kawahara et al.
JOURNAL OF HEPATOLOGY (2011)
Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis of 15 Years of Experience
Vincenzo Mazzaferro et al.
LIVER TRANSPLANTATION (2011)
Conversion to Everolimus in Maintenance Liver Transplant Patients: A Multicenter, Retrospective Analysis
Faouzi Saliba et al.
LIVER TRANSPLANTATION (2011)
A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Guo-Ying Wang et al.
PLOS ONE (2011)
Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria
Deniz Balci et al.
TRANSPLANT INTERNATIONAL (2011)
Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers
Valentina Rosa Bertuzzo et al.
TRANSPLANTATION (2011)
Effects of Risk Factors and Ki-67 on Rates of Recurrence on Patients Who Have Undergone Liver Transplant for Hepatocellular Carcinoma
S. Aktas et al.
TRANSPLANTATION PROCEEDINGS (2011)
Advagraf De Novo in Liver Transplantation: A Single-Center Experience
J. Ortiz de Urbina et al.
TRANSPLANTATION PROCEEDINGS (2011)
University of Modena Experience in HIV-Positive Patients Undergoing Liver Transplantation
F. Di Benedetto et al.
TRANSPLANTATION PROCEEDINGS (2011)
Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
M. Masetti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation
P. Trunecka et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation
Michael A. Zimmerman et al.
CLINICAL TRANSPLANTATION (2010)
Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma
Christian Toso et al.
HEPATOLOGY (2010)
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
Marco Vivarelli et al.
TRANSPLANTATION (2010)
Timing of Conversion to Mammalian Target of Rapamycin Inhibitors Is Crucial in Liver Transplant Recipients With Impaired Renal Function at Transplantation
C. Schleicher et al.
TRANSPLANTATION PROCEEDINGS (2010)
Sirolimus in Liver Transplant Recipients: A Large Single-Center Experience
M. Vivarelli et al.
TRANSPLANTATION PROCEEDINGS (2010)
Living Donor Liver Transplantation for Hepatocellular Carcinoma: Increased Recurrence but Improved Survival
Khashayar Vakili et al.
LIVER TRANSPLANTATION (2009)
Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Srinath Chinnakotla et al.
LIVER TRANSPLANTATION (2009)
Hepatocellular Carcinoma and Liver Transplantation: A 12-Year Experience
M. A. Varona et al.
TRANSPLANTATION PROCEEDINGS (2009)
Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors Reassessment of Risk Factors for Tumor Recurrence
Marco Vivarelli et al.
ANNALS OF SURGERY (2008)
Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria
Hyun Young Woo et al.
LIVER INTERNATIONAL (2008)
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Michael A. Zimmerman et al.
LIVER TRANSPLANTATION (2008)
Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma
Mauricio Silva et al.
LIVER TRANSPLANTATION (2008)
Sirolimus therapy in liver transplant patients: An initial experience at a single center
A. Nocera et al.
TRANSPLANTATION PROCEEDINGS (2008)
Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation
M. Kiyici et al.
TRANSPLANTATION PROCEEDINGS (2008)
Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
J. Zhou et al.
TRANSPLANTATION PROCEEDINGS (2008)
Recurrence of hepatocellular carcinoma after liver transplantation
A. Escartin et al.
TRANSPLANTATION PROCEEDINGS (2007)
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects
Christian Toso et al.
TRANSPLANTATION (2007)
Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation
Thomas Soliman et al.
TRANSPLANT INTERNATIONAL (2007)
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: Poststudy surveillance to 3 years
J. G. O'Grady et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression
M Vivarelli et al.
LIVER TRANSPLANTATION (2005)
Chronic renal failure after transplantation of a nonrenal organ
AO Ojo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hypertension and renal dysfunction in long-term liver transplant recipients
TA Gonwa
LIVER TRANSPLANTATION (2001)
mTOR inhibitors: An overview
P Neuhaus et al.
LIVER TRANSPLANTATION (2001)
分享论文
